ZGNX
Zogenix, Inc.

4,910
Loading...
Loading...
At Zogenix, our core strategy is to develop and commercialize differentiated central nervous system (CNS) and pain therapeutics that can address significant unmet medical needs or overcome limitations of existing products. We are a specialty pharmaceutical company with two proprietary product candidates in late-stage development for the treatment of central nervous system disorders and pain. Our lead product candidate, sumatriptan DoseProââ??¢, enables needle-free subcutaneous delivery of sumatriptan for the treatment of acute migraine. Our second product candidate, ZX002, is a novel controlled release formulation of hydrocodone for the treatment of chronic pain.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Zogenix Inc?
What is the 52-week high for Zogenix Inc?
What is the 52-week low for Zogenix Inc?
What is Zogenix Inc stock price today?
What was Zogenix Inc stock price yesterday?
What is the PE ratio of Zogenix Inc?
What is the Price-to-Book ratio of Zogenix Inc?
What is the 50-day moving average of Zogenix Inc?

Latest ZGNX News

View
No ZGNX news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.